Wang, C., Wu, L., Xu, X., WANG, S. (2025). Venetolax plus azacitidine is effective maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with intermediate/high-risk Acute Myeloid Leukemia. Blood. https://doi.org/10.1182/blood-2025-6995